ロード中...
Super enhancer associated RAI14 is a new potential biomarker in lung adenocarcinoma
PURPOSE: Tyrosine kinase inhibitors (TKIs) are widely used to treat lung adenocarcinoma patients with EGFR mutations or ALK-fusions. However, patients with wild-type genes or TKIs-resistant mutations lack effective therapeutic targets. Extensive studies reveal that super enhancer (SE), a large cis-r...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739635/ https://ncbi.nlm.nih.gov/pubmed/29285248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22165 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|